期刊文献+

miRNA-194在骨肉瘤中靶基因的预测和验证 被引量:1

The Prediction and Verification of Target Genes of miRNA-194 in Osteosarcoma
原文传递
导出
摘要 目的:对miRNA-194在骨肉瘤中的作用机制进行探索和研究,为研究miRNA-194在骨肉瘤中的作用及可能的生物治疗提供理论依据和研究基础。方法:使用生物信息学软件对miRNA-194在骨肉瘤中可能的靶基因进行预测,并在基因水平和蛋白水平进行相应的验证。此外,利用荧光素酶基因报告实验对其靶基因(CDH2)进行DNA水平的直接验证。结果:使用生物信息学软件预测出了多个可能的潜在靶基因(367个,6014个和212个);荧光素酶基因报告实验显示野生PTEN-3'-UTR在miRNA-194上调组明显的低表达,同时下调组明显的高表达(P<0.05);同时,western实验显示在蛋白水平miRNA-194直接靶向作用于CDH2(P<0.05),而在m RNA水平则无明显作用(P>0.05)。结论:经预测和验证,CDH2是miRNA-194在骨肉瘤中的直接靶基因,为接下来关于miRNA-194在骨肉瘤中的各项研究奠定了良好的实验基础。 Objective: To forecast and verify the target genes of miRNA-194 in human osteosarcoma and establish some theoretical basis for osteosarcoma treatment and element experience of miRNA-194 for further research. Methods: Potential target gene of miRNA-194 was predicted using bioinformatics and were verified in gene and protein levels. Moreover, luciferase reporter assay was used to confirm whether CDH2 was direct targets of miRNA-194. Results: Potential target genes of miRNA-194 were predicted by using bioinformatics. Moreover, luciferase activity of the wild-type PTEN-3'-UTR reporter was significantly suppressed in miRNA-194up-regulation group compared with other groups in SOSP-9607 cells(P〈0.01) while down-regulation group could significantly increase it(P〈0.01). At the same time, western blot analysis revealed that miRNA-194 expression could affect the expression of CDH2 protein while there was no significant difference on m RNA level(P〉0.05). Conclusion: CDH2, one target gene of miRNA-194, was predicted and verified, which provided the theoretical basis for the next study of miRNA-194 in the osteosarcoma.
出处 《现代生物医学进展》 CAS 2016年第18期3581-3585,共5页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(31500856)
关键词 miRNA-194 CDH2 机制 骨肉瘤 MicroRNA-194 CDH2 Mechanism Osteosarcoma
  • 相关文献

参考文献28

  • 1He JP, Hao Y, Wang XL, et al. Review of the molecular pathogenesis of osteosarcoma [J]. Asian Pacific journal of cancer prevention: APJCP, 2014, 15(15): 5967-5976.
  • 2Ottaviani G, Jaffe N. The epidemiology of osteosarcoma [J]. Cancer Treat Res, 2009, 15(2): 3-13.
  • 3Mirabello L, Troisi R J, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: Data fxom the surveillance, epidemiology, and end results program [J]. Cancer, 2009, 115 (7): 1531-1543.
  • 4Allison DC, Carney SC, Ahlmann ER, et al. A meta-analysis of osteosarcoma outcomes in the modem medical era[J]. Sarcoma, 2012, 20(12): 70-72.
  • 5Cheng Q, Yi B, Wang A, et al. Exploring and exploiting the fimdamental role of microRNAs in tumor pathogenesis [J]. OncoTargets and therapy, 2013, 6(4): 1675-1684.
  • 6Tan P, Zou C, Yong B, et al. Expression and prognostic relevance of prame in primary osteosareoma [J]. Biochem Biophys Res Commun, 2012, 419(4): 801-808.
  • 7Hammond SM. An overview of micromas[J]. Advanced drug delivery reviews, 2015, 8(7): 3-14.
  • 8韩康,赵廷宝,卞娜,蔡成魁,颜世举,王鑫,肖春,沙浩,董川,杨彤涛,周勇,马保安.利用慢病毒载体观察microRNA-194对人骨肉瘤细胞系U2-OS生物学特性的影响[J].现代生物医学进展,2014,14(23):4401-4405. 被引量:3
  • 9Han K, Chert X, Bian N, et al. Microma profiling identifies mir-195 suppresses osteosarcoma cell metastasis by targeting cc ndl [J]. Oncotarget, 2015, 6(11): 8875-8889.
  • 10Baffa R, Fassan M, Volinia S, et al. Microma expression profiling of human metastatic cancers identifies cancer gene targets [J]. The Journal of pathology, 2009, 219(2): 214-221.

二级参考文献18

  • 1Ambros V. microRNAs: tiny regulators with great potential [J]. Cell, 2001, 107:823-826.
  • 2Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116:281-297.
  • 3Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease[J]. Developmental cell, 2006, 11: 441-450.
  • 4Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors[J]. Developmental biology, 2007, 302:1-12.
  • 5Cheng Q, Yi B, Wang A, et al. Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis [J]. OncoTargets and therapy, 2013, 6:1675-1684.
  • 6Clark JC, Dass CR, Choong PF. A review of clinical and molecular prognostic factors in osteosarcoma [J]. Journal of cancer research and clinical oncology, 2008, 134:281-297.
  • 7Kansara M, Thomas DM. Molecular pathogenesis of osteosarcoma[J]. DNA and cell biology, 2007, 26:1-18.
  • 8Xia T, O'Hara A, Araujo I, et al. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3 [J]. Cancer research, 2008, 68:1436-1442.
  • 9Deng S, Calin GA, Croce CM, et al. Mechanisms of microRNA deregulation in human cancer[J]. Cell cycle (Georgetown, Tex), 2008, 7:2643-2646.
  • 10Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers[J]. Nature, 2005, 435:834-838.

共引文献2

同被引文献7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部